SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-017869
Filing Date
2020-07-20
Accepted
2020-07-20 07:00:17
Documents
3
Period of Report
2020-07-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124307-8k_soligenix.htm 8-K 17775
2 PRESS RELEASE OF SOLIGENIX, INC. DATED JULY 20, 2020 ea124307ex99-1_soligenix.htm EX-99.1 38847
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6287
  Complete submission text file 0001213900-20-017869.txt   66797
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14778 | Film No.: 201034990
SIC: 2834 Pharmaceutical Preparations